| OPKO HEALTH INC. DL-,01 |
| USA |
| Gesundheit |
| US68375N1037 / A0MUUJ |
| XCY (Frankfurt) / OPK (NASDAQ) |
| FRA:XCY, ETR:XCY, XCY:GR, NASDAQ:OPK |
| - |
| https://www.opko.com/ |
|
OpKO Health Inc. is a multinational biopharmaceutical and diagnostics company operating through two primary segments: Pharmaceuticals and Diagnostics. In the Pharmaceuticals segment, it develops and commercializes therapies such as Rayaldee, FDA-appr..
>Volltext.. |
| 738.79 Mio. EUR |
| 762.42 Mio. EUR |
| 527.38 Mio. EUR |
| -110.68 Mio. EUR |
| -196.12 Mio. EUR |
| -0.26 EUR |
| 344.8 Mio. EUR |
| 320.73 Mio. EUR |
| -155.15 Mio. EUR |
| 2.52 |
| -24.99% |
| -273.54% |
| - |
| - |
| - |
| OPKO HEALTH |
| 28.03.26 |
|